VFM
MRNA icon

Vision Financial Markets’s Moderna MRNA Stock Holding History

Vision Financial Markets’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7K Hold
100
– – 0.01% 277
2026
Q1 		$5.08K Hold
100
– – 0.01% 285
2025
Q4 		$2.95K Hold
100
– – ﹤0.01% 297
2025
Q3 		$2.58K Hold
100
– – ﹤0.01% 328
2025
Q2 		$2.76K Hold
100
– – ﹤0.01% 311
2025
Q1 		$2.83K Hold
100
– – ﹤0.01% 293
2024
Q4 		$4.16K Buy
+100
New +$4.78K ﹤0.01% 218

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Vision Financial Markets's MRNA Position: Q2 2026 in Review

Vision Financial Markets held its Moderna (MRNA) position steady in Q2 2026 at 100 shares worth $7K. The position accounts for 0.01% of the portfolio, ranked #277.

Vision Financial Markets first reported a position in MRNA in Q4 2024 and has held it in 7 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Vision Financial Markets held 100 shares of Moderna worth $7K as of Q2 2026.
  • Vision Financial Markets left its Moderna share count unchanged in Q2 2026.
  • Moderna made up 0.01% of Vision Financial Markets's portfolio in Q2 2026, its #277 holding.
  • Vision Financial Markets first reported a position in Moderna in Q4 2024 and has held it in 7 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Vision Financial Markets's 13F filing for Q2 2026, filed 24 Jul 2026.